Meet Our Management Team
Stéphane Gagné, President & CEO
Co-Founder of Ovensa and three other companies, Mr. Gagné holds 20 years of experience in the pharmaceutical (anticancer drugs and drug delivery), cosmetics and nutritional supplements industries. He was instrumental to the growth of Aeterna-Zentaris, a company that was developing an angiogenesis inhibitor for non-small cell lung cancer. He was also a co-founder of Constab Pharmaceutical, a company developing a drug delivery system using alpha-fetoprotein. Mr. Gagné also contributed to the international expansion of Atrium Biotechnologies and several Canadian private and public companies. He is recognized for his leadership, for building teams, growing sales and for his negotiation skills. He holds 2 bachelor degrees (Economics and Multidisciplinary), has a Master Degree in Business Administration and speaks several languages.
Philippe Tremblay, VP, Research & Strategic Development
Co-Founder of Ovensa. With over 15 years of R&D and commercialization experience in pharmaceutical, diagnostics, and biotechnology industries, he is leading the advancement of the Ovensa’s immuno-oncology siRNA lead candidate program as a tumor microenvironment modulator to improve response rates of cancer immunotherapy utilizing the PD-1/PD-L1 checkpoint. He is also leading R&D partnership programs including the development of non lipidic RNA nanotherapeutics through the TRIOZANTM Platform and a key collaboration with Takeda Pharmaceutical that involves the development of a mAb nanotherapeutic in a CNS indication. Prior to Ovensa, he held hospital sales & marketing roles in diabetes and cardiovascular diagnostic areas at Hoffmann-La Roche. He also held regulatory affairs and commercial roles at Atrium Innovations, a Nestlé Health Science company. He received an MBA in pharmaceutical management, a M.Sc. in molecular medicine (Physiology- Endocrinology/Hormone-Dependent Cancers), and a B.Sc. in biochemistry from Université Laval.